NATUREX : Number of shares and voting rights as of December 2010


Au 31.12.2010

Total number of outstanding shares forming the capital
- 4,959,935 ordinary shares under ISIN FR0000054694
- 1,450,996 preferred shares under ISIN FR0010833251
Total number of outstanding shares forming the capital
with voting rights
- 4,959,935 ordinary shares under ISIN FR0000054694
- 0 shares from stock-options under ISIN FR0000054694
Number of shares with double voting rights 86,750
Total number of gross voting rights 5,046,685
Number of shares without voting rights
- 7,000 registered shares
- 5 632 actions sous la forme porteur dans le cadre du contrat de liquidité
- 7,000
- 5,632
Total number of exercisable voting rights* 5,034,053

*Real number of voting rights = total number of voting rights - number of shares without voting rights

Download our press releases and other publications on

Naturex is listed on NYSE Euronext Paris since October 1996 - Compartment B.

Number of shares forming the capital: 6,410,931 4,959,935 ordinary shares (ISIN FR0000054694) 1,450,996 preferred shares (ISIN FR0000010833251) Naturex is a component stock of the following indices: SBF250, CAC All Shares, CAC Mid&Small 190, CAC Small 90, Gaïa Index

ISIN: FR0000054694 (NRX) - Reuters: NATU.PA - Bloomberg: NRX:FP

About Naturex

Naturex is the world leader in specialty plant-based natural ingredients.

The Group, organized around three strategic markets - Food&Beverage, Nutrition&Health and Personal Care - , manufactures and markets natural ingredients for food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex, whose head office is based in Avignon (France), employs more than 950 persons and benefits from high performance industrial resources through 11 production sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), in Morocco, in the United States, in Brazil and in Australia. Moreover, the Group has a worldwide geographical presence through a dedicated sales network in 16 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E, Thailand, Singapore, Japan, China, Australia, the United States, Australia).

Naturex's sound performance is linked to the fast-growing demand for natural ingredients and its capacity to provide manufacturers customized solutions with the means to meet the requirements of their end consumers.

Its strength lies in its ability to position itself on specific products which constitute niche markets.

Contacts Naturex

Jacques Dikansky
President and CEO
Tél : +33 (0)4 90 23 96 89

Carole Alexandre
Investor Relations
Tél : +33 (0)4 90 23 78 28
Thierry Lambert
Vice-President and CFO
Tél : +33 (0)4 90 23 96 89

Contacts Actus

Anne Catherine Bonjour
Press Relations
Tél : +33 (0)1 53 67 36 93
Jérôme Fabreguettes-Leib
Investor Relations
Tél : +33 (0)1 77 35 04 36
Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :
- Communiqué intégral et original au format PDF : © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur
Receive by email the next press releases of the company by registering on, it's free

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant